Sano Genetics/X
Jul 31, 2025, 15:37
Sano Genetics: “Unreasonable” Leadership with Benny Sorenson of Hemab
Sano Genetics shared an inviting post on X:
”Tune in to Episode 198 of The Genetics Podcast.
This week, we’re joined by Benny Sorensen, CEO of Hemab Therapeutics. Tune in to hear about how Benny’s persistence and “unreasonable” leadership led to Hemab’s first program, how Hemab is reimagining clotting therapies by centering patient voices, and the value of their multi-modality and collaborative approach.”
Listen to the Apple Podcast here.
Listen to the YouTube Podcast here.
Stay tuned with Hemostasis Today.
-
May 14, 2026, 06:39Khushali Pandit: Innovations in Cell Therapy Manufacturing Highlighted at ISCT 2026
-
May 14, 2026, 06:09Sophia Delicou: A Shift Toward Function-Centered Care for Patients with Hemoglobinopathies
-
May 14, 2026, 06:04Tim Grisham: The Lasting Impact of Nurses in Hemophilia Care and Care Continuity
-
May 14, 2026, 05:19Tackling Cardiovascular Comorbidities in Bleeding Disorders – EHC
-
May 13, 2026, 17:38Rohit Sankar J. Snscphysio: Recognizing the Clot Before It Becomes Life-Threatening
-
May 13, 2026, 16:41Seema Dawood: When Elevated Platelets Signal a Myeloproliferative Neoplasm
-
May 13, 2026, 16:38Kari Tikkinen: Defining Thromboprophylaxis in MIBC Neoadjuvant Care
-
May 13, 2026, 16:28Nadia Tarhini: Evaluating the Risk of Recurrent Thrombosis in Children with ALL
-
May 13, 2026, 16:01Sifat Jubaira: When Low MCV Meets High Platelets